At this year’s SITC 21, we will host a Launch Exhibition for our next-generation Plasma Biomarker Discovery solution. The launch also features a Launch Webinar on November 9th.
Biognosys is proud to present a scientific poster highlighting the results from our ultra-deep, unbiased plasma proteomics workflow in a pan-cancer clinical trial. Additionally, Parker Institute for Cancer Immunotherapy (PICI) will share the results of our proteomic analysis in the PRINCE trial in metastatic pancreatic cancer.
We are excited to meet you in person at booth #609.
Authors: Kristina Beeler, Dr.; Roland Bruderer, PhD; Marco Tognetti, PhD; Kamil Sklodowski, PhD; Sebastian Mueller, PhD; Dominique Kamber; Lukas Reiter, PhD
Poster Number: 90
Authors: Deena M. Maurer, PhD; Jia Xin Yu, PhD; Kamil Sklodowski, PhD; Marco Tognetti, PhD; Lukas Reiter, PhD; Roland Bruderer, PhD; Jakob Vowinckel, PhD; Shannon M. Pfeiffer, MS; Mark H. O’Hara, MD; Eileen M. O’Reilly, MD; Robert A. Wolff, MD; Zev A. Wainberg, MD; Andrew H. Ko, MD; Osama Rahm, MD; George A. Fisher, MD; Jaclyn P. Lyman, MS; Christopher R. Cabanski, PhD; Pier Federico Gherardini, PhD; Jill O’Donnell-Tormey, PhD; Theresa M. LaVallee, PhD; Robert H. Vonderheide, MD, PhD; Lacey J. Kitch, PhD
Poster Number: 343
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
